4 unknown, 2 completed, 2 not yet recruiting. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Unknown 4, Completed 2, Not yet recruiting 2 |
Follow HBV: new trials by email Literature Review of HBV trials Research Report on HBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B Peginterferon alfa-2b Injection - HBV, Chronic Hepatitis B Virus | Phase 4 | Not yet recruiting | Nanfang Hospital, Southern Medical University | 113 | 2026-01-01 | 2025-11-17 |
| Antiviral Therapy in Infants With HBV Infection Lamivudine, Interferon - HBV | Phase 4 | Not yet recruiting | Beijing 302 Hospital | 60 | 2024-08-01 | 2024-07-23 |
| The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs Tenofovir alafenamide - HBV, Inflammatory Arthritis | Phase 4 | Unknown | Taipei Veterans General Hospital, Taiwan | 108 | 2021-08-15 | 2021-08-12 |
| Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant Tenofovir Alafenamide 25 MG - HBV, POST LIVER TRANSPLANT | Phase 4 | Unknown | Fudan University | 150 | 2021-07-29 | 2021-09-30 |
| Tenofovir Alafenamide in HBV Related Decompensated Liver Tenofovir Alafenamide Tablets - HBV | Phase 4 | Unknown | Kaohsiung Medical University Chung-Ho Memorial Hospital | 100 | 2020-09-01 | 2020-12-24 |
| A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir Tenofovir Alafenamide (TAF) - HBV | Phase 4 | Unknown | The First Hospital of Jilin University | 8 | 2019-08-01 | 2019-07-26 |
| Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy Tenofovir DF - Pregnancy, HBV | Phase 4 | Completed | Hopital Lariboisière | 37 | 2012-07-01 | 2017-04-28 |
| Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV Telbivudine - HBV | Phase 4 | Completed | Yi-Hua Zhou | 335 | 2012-04-01 | 2014-12-02 |
Arthritis (1) · Hepatitis B, Chronic (1)
Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Disease Attributes (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis B (1) · Hepatitis, Chronic (1) · Hepatitis, Viral, Human (1) · Infections (1) · Joint Diseases (1) · Liver Diseases (1) · Musculoskeletal Diseases (1)
tenofovir alafenamide (4) · Interferons (1) · Lamivudine (1) · Telbivudine (1) · Tenofovir (1) · peginterferon alfa-2b (1)
Beijing 302 Hospital (1) · Fudan University (1) · Hopital Lariboisière (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · Nanfang Hospital, Southern Medical University (1) · Taipei Veterans General Hospital, Taiwan (1) · The First Hospital of Jilin University (1) · Yi-Hua Zhou (1)
China (4) · France (1) · Taiwan (1)
Jian Zhou (1) · Junliang Fu (1) · Ming-Lung Yu, Professor (1) · Yali Hu, MD, PhD (1) · Yongyin Li, doctor (1)